| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 08:00-08:10 |
Robotic Y90 Radioembolization |
Edward W. Lee | UCLA Medical Center, USA |
| 2 | 08:10-08:20 |
SIRT for HCC: From Palliative to Curative Intent |
Pi-Yi Chang | Taichung Veterans General Hospital, Taiwan, China |
| 3 | 08:20-08:30 |
Voxel based dosimetry for Y90 SIRT - impact on planning and outcomes |
Sanjay Saran Baijal | Medanta – The Medicity, India |
| 4 | 08:30-08:40 |
Transarterial radioembolization in Asian HCC management |
Jin Woo Choi | Seoul National University Hospital, ROK(Republic of Korea) |
| 5 | 08:40-08:50 |
Y90 glass microsphere-SIRT for downstaging and bridging for advanced HCC: clinical evidence and practice |
Riad Salem | Northwestern Medicine |
| 6 | 08:50-09:00 |
Yttrium-90 selective internal radiation therapy followed by lenvatinib plus sintilimab for unresectable intermediate-to-advanced hepatocellular carcinoma: the phase II SIRLENS-90 tria |
Jing-Jun Huang | The Second Affiliated Hospital of Guangzhou Medical University, China |
| 7 | 09:00-09:30 |
Discussion |
A LL |
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 10:00-10:10 |
Radioembolization and Immunotherapy: Evolving Strategies in the Treatment of Advanced Liver Tumors |
Jon C. Davidson | University Hospitals Cleveland Medical Center, USA |
| 2 | 10:10-10:20 |
Role of Radioembolization in Treatment of Advanced HCC |
Rickie Lik-Fai Cheng | Princess Margaret Hospital, Hong Kong, China |
| 3 | 10:20-10:30 |
Radioembolization: Have we reached peak technology? |
David M. Liu | University of British Columbia, Canada |
| 4 | 10:30-10:40 |
⁹⁰Y transarterial radioembolization combined with immunotherapy in hepatocellular carcinoma: a bibliometric analysis. |
Hai-Dong Zhu | Zhongda Hospital, Southeast University, China |
| 5 | 10:40-10:50 |
Transarterial radioembolization |
Hyo-Cheol Kim | Seoul National University Hospital, ROK(Republic of Korea) |
| 6 | 10:50-11:00 |
⁹⁰Y-SIRT for Stepwise Downstaging and Conversion of HCC: Clinical Experience from Beijing Tsinghua Changgung Hospita |
Lin Zhang | Beijing Tsinghua Chang Gung hospital, China |
| 7 | 11:00-11:30 |
Discussion |
A LL |
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 12:00-12:10 |
Treating Liver Cancers with HepaSphere |
Hideki Iwamoto | Kurume University, Japan |
| 2 | 12:10-12:20 |
My deTACE Practice for HCC Management |
Dong Il Gwon | Medical Center University of Ulsan College of Medicine, ROK(Republic of Korea) |
| 3 | 12:20-12:30 |
Application of Small-Particle deTACE in ICC Therapy |
Hai-Peng Yu | Tianjin Medical University Cancer Institute & Hospital, China |
| 4 | 12:30-13:00 |
Pannel discussion |
A LL |
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 13:00-13:10 |
Visceral artery aneurysms |
Robert Morgan | St George’s University Hospitals, UK |
| 2 | 13:10-13:20 |
Endovascular treatment of visceral aneurysms |
Hicham Kobeiter | Henri Mondor University Hospital, France |
| 3 | 13:20-13:30 |
Endovascular interventions for acute and chronic mesenteric ischemia |
KIANG HIONG TAY | Singapore General Hospital, Singapore |
| 4 | 13:30-13:40 |
Challenging Cases: Management of Large Visceral Aneurysm |
Wing Chung Law | Prince of Wales Hospital, Hong Kong, China |
| 5 | 13:40-13:50 |
Renal artery interventions in FMD and atherosclerosis |
Gerard S. Goh | The Alfred Hospital and Monash University, Australia |
| 6 | 13:50-14:00 |
Application of Non-adhesive Liquid Embolic Agents in Peripheral Vascular Diseases |
Yi Zhang | Zhongda Hospital, Southeast University, China |
| 7 | 14:00-14:30 |
Discussion |
A LL |
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 15:00-15:10 |
Real-World Embolization Strategies in CARTO/BRTO (tentative) |
Kaishu Tanaka | Osaka General Medical Center, Japan |
| 2 | 15:10-15:20 |
CARTO/PARTO for Hepatic Encephalopathy |
Edward W. Lee | UCLA Medical Center, USA |
| 3 | 15:20-15:30 |
The necessity of collateral circulation embolism during TIPS |
Jian-Jun Li | Beijing Youan Hospital, Capital Medical University, China |
| 4 | 15:30-15:40 |
TIPS and variceal embolization for Hepatocellular Carcinoma Patients with Portal Vein Tumour Thrombus |
Wei-Zhong Zhou | Jiangsu Province Hospital (The First Affilated Hospital with Nanjing Medical University), China |
| 5 | 15:40-15:50 |
TIPS embolization strategy with Hydrogel coil |
Qi-Chen Feng | Peking University Third Hospital, China |
| 6 | 15:50-16:00 |
The application value of artificial intelligence in the treatment of portal hypertension in liver cirrhosis with TIPS |
Zhang Cheng | Suzhou Municipal Hospital, China |
| 7 | 16:00-16:10 |
Discussion |
Chuan-Sheng Zheng | Union Hospital, Huazhong University of Science and Technology, China |
| 8 | 16:10-16:20 |
Disscusion |
Hui Xue | The First Alliliated Hospital of Xi'an Jiaotong University, China |
| 9 | 16:20-16:30 |
Disscusion&Closing |
Xiao-Li Zhu | The First Affiliated Hospital of Soochow University, China |
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 16:30-16:40 |
From Ablation to Embolization: Optimizing Outcomes and Technique for Benign Thyroid Nodules |
Pipit Pituvong | Golden Jubilee Medical Center, Thailand |
| 2 | 16:40-16:50 |
Comparison of radiofrequency and microwave ablation for the treatment of benign thyroid nodules |
Cem Yucel | Prof. Dr. Cem Yucel Color Doppler and Interventional Ultrasound Clinic, Turkiye |
| 3 | 16:50-17:00 |
Thyroid Ablation, changing the map of treatment |
Osama Hetta | Ain Shams University, Egypt |
| 4 | 17:00-17:10 |
Radiofrequency Ablation of Thyroid Lesions: Technical Pearls and Latest Updates |
Kiujing James Fung | Pamela Youde Nethersole Eastern Hospital, Hong Kong, China |
| 5 | 17:10-17:30 |
Discussion |
A LL |